
Minister of Health Memişoğlu visited Samsung Medison, IFEZ and Celltrion in South Korea and examined the studies in the field of health technologies and biopharmaceuticals.
AI-generated summary
According to the ministry statement, Memişoğlu made inspections in health and technology centers in South Korea.
According to the statement made by the ministry, Memişoğlu visited Samsung Medison, which operates in the field of medical imaging technologies in South Korea.
Then, Memişoğlu went to IFEZ, one of the world's largest biotechnology, pharmaceutical production and health technologies centers, and examined the activities in the field of health and technology and made evaluations on the development of innovative initiatives, technology-oriented investments and international cooperation opportunities.
Memişoğlu also visited the Celltrion company, which operates in the field of biopharmaceuticals, and received information from the authorities about the studies on the development and production of biological drugs.
During the meetings, the development of knowledge and experience sharing in the field of health and possible cooperation opportunities for innovative health technologies were discussed.

In a comprehensive study examining 270 health outcomes, researchers from China Medical University found that individuals with blood type B were 28% more likely to develop Type 2 diabetes than other groups.

New accusations have emerged regarding the alleged reuse of disposable materials at Kahramanmaraş Sütçü İmam University Hospital. Health World Association President Hanifi Çöplü claimed that the doctor and nurse responsible for sterilization set up a front company through their relatives and sold the used products as new.

According to the 2026-TUS 2nd Term results announced by ÖSYM, quotas in pediatric surgery and child health branches remained largely empty. Experts drew attention to working conditions and malpractice pressure.

An international study conducted in England with 15.9 million participants revealed that untreated ADHD increases the risk of early death by 70%, while prescription medications significantly reduce this risk.

A new scientific study conducted in Canada revealed that the areas of cellular and vascular microdamage in the brains of individuals who consume most of their daily diet from ultra-processed foods are significantly increased.

Side effects such as nausea and fatigue experienced by patients using GLP-1 weight loss and diabetes drugs have created a billion-dollar food supplement market. Uncontrolled recommendations on social media are growing the industry.